Picture of Thermogenesis Holdings logo

THMO — Thermogenesis Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro Cap

ThermoGenesis rises on patent applications for COVID-19 testing device

** Shares of cell-based therapy company  THMO.O  rise 5.4%
to $6.16
    ** Co files patent applications for a point-of-care device
which improves the speed and accuracy of certain tests to detect
COVID-19 antibodies from a single drop of blood  urn:newsml:reuters.com:*:nPn7zWDZVa
    ** THMO is also developing convalescent plasma and antibody
therapeutic approaches against COVID-19 in collaboration with
joint venture partner ImmuneCyte Life Sciences Inc  urn:newsml:reuters.com:*:nPn4TGr9Pa
    ** Including session's gain, shares up ~40% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))

Recent news on Thermogenesis Holdings

See all news